{
  "slug": "shiratronics-inc",
  "name": "Shiratronics, Inc",
  "description": "ShiraTronics, Inc. is a clinical-stage medical device company dedicated to advancing neurostimulation therapies for people living with chronic migraine. They are developing the first purpose-built device in the emerging category of Implantable Extracranial Neuromodulation Systems (IENs).",
  "url": "https://optimly.ai/brand/shiratronics-inc",
  "websiteUrl": "https://prnewswire.com/",
  "logoUrl": "https://logo.clearbit.com/prnewswire.com",
  "baiScore": 57.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Neurostimulation Systems",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-16T01:39:32.573Z",
  "verifiedVitals": {
    "website": "https://prnewswire.com",
    "category": "Medical Device Company",
    "what_it_does": "ShiraTronics, Inc. is a clinical-stage medical device company dedicated to advancing neurostimulation therapies for people living with chronic migraine. The company is developing the first purpose-built device in the emerging category of Implantable Extracranial Neuromodulation Systems (IENs), designed specifically for chronic migraine.",
    "primary_audience": "The primary audience includes patients suffering from chronic migraine and the physicians who care for them.",
    "core_product": "The core product is the investigational ShiraTronics system, a fully implantable neurostimulator designed specifically for chronic migraine.",
    "pricing_model": {
      "kind": "unknown",
      "detail": "The company's investigational system has received Category III CPT codes for bilateral supraorbital-occipital neurostimulator services, effective January 1, 2027. However, these codes do not establish coverage or payment, which remain payer-determined."
    }
  },
  "intentTags": {
    "problemIntents": [
      "Inadequate chronic migraine management with existing therapies",
      "Limitations of medications and externally worn migraine devices",
      "Need for discreet, continuous migraine prevention",
      "Patient burden with daily routines for migraine treatment"
    ],
    "solutionIntents": [
      "Implantable neuromodulation for chronic migraine",
      "Extracranial neurostimulation therapy",
      "Continuous, preventative migraine treatment",
      "Medical device innovation for neurological disorders",
      "Establishment of new procedural categories in medicine"
    ],
    "evaluationIntents": [
      "Clinical trial results for neuromodulation devices",
      "FDA regulatory approval process for medical devices (PMA)",
      "Safety and efficacy of implantable migraine therapies",
      "Reimbursement and CPT coding for novel medical procedures",
      "Quality of life improvements for chronic migraine patients"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789819898387
}